BrdU (Bromodeoxyuridine)

製品コードS7918 バッチS791806

印刷

化学情報

 Chemical Structure Synonyms 5-Bromo-2'-deoxyuridine, BUdR Storage
(From the date of receipt)
3 years -20°C(in the dark) powder
化学式

C9H11BrN2O5

分子量 307.1 CAS No. 59-14-3
Solubility (25°C)* 体外 DMSO 61 mg/mL (198.63 mM)
Ethanol (warmed with 50ºC water bath) 3 mg/mL (9.76 mM)
Water Insoluble
体内 (毎回新しく調製した物を用意してください)
Clear solution
4%DMSO Corn oil
7.5mg/ml Taking the 1 mL working solution as an example, add 40 μL of 187.5 mg/ml clear DMSO stock solution to 960 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液(一定の濃度)を調合する

生物活性

製品説明 BrdU (Bromodeoxyuridine) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells.
in vitro

In RG2 rat glioma cells, Bromodeoxyuridine induces a progressive, dose-responsive suppression of cancer cell line and cancer stem cell population expansion. In H9 cells and BJ fibroblasts, Bromodeoxyuridine alters the cell cycle profile. [1]

BrdU is stably integrated into the DNA, and thus can be used in assessment of cell proliferation and other cell procession. [2]

in vivo

In rat glioma RG2 tumor model, Bromodeoxyuridine (300 mg/kg, i.p. or 0.8 mg/ml, p.o.) significantly slows tumor progression. [1]

プロトコル(参考用のみ)

細胞アッセイ 細胞株 RG2 rat glioma cells
濃度 ~ 50 µM
反応時間 24 hours
実験の流れ

Cultures are initially plated at 2000 cells/cm2 and are quantified with a Z2 Coulter Counter. RG2 rat glioma cells are treated once with 0, 1, 10, or 50 µM BrdU for 24 hours, and cumulative growth curves were obtained over 18 days. Control and treated cells are quantified and replated at equal densities on days 5, 12, and 18 after treatment.

動物実験 動物モデル Rats bearing RG2 tumors
投薬量 300 mg/kg (i.p.); 0.8 mg/ml (p.o.)
投与方法 i.p. or p.o.

カスタマーフィードバック

Data from [Data independently produced by , , PLoS One, 2016, 11(11):e0166386.]

Data from [Data independently produced by , , PLoS One, 2016, 11(11):e0166386]

Data from [Data independently produced by , , Int J Ophthalmol, 2017, 10(4):507-514]

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII [ Heliyon, 2024, 10(3):e24779] PubMed: 38314260
miR-432-5p Inhibits the Ferroptosis in Cardiomyocytes Induced by Hypoxia/Reoxygenation via Activating Nrf2/SLC7A11 Axis by Degrading Keap1 [ Anal Cell Pathol -Amst), 2023, 2023:1293200] PubMed: 37822721
CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer [ Am J Cancer Res, 2021, 11(2):389-415] PubMed: 33575078
Activation of 6-8-week-old new mature adult-born dentate granule cells contributes to anxiety-like behavior [ Neurobiol Stress, 2021, 15:100358] PubMed: 34195305
YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway [ Int J Ophthalmol, 2021, 14(4):489-496] PubMed: 33875937
lncRNA Oip5-as1 Attenuates Myocardial Ischaemia/Reperfusion Injury by Sponging miR-29a to Activate the SIRT1/AMPK/PGC1α Pathway [ Cell Prolif, 2020, 28;e12818] PubMed: 32468629
Neferine inhibits growth and migration of gastrointestinal stromal tumor cell line GIST-T1 by up-regulation of miR-449a. [ Biomed Pharmacother, 2019, 109:1951-1959] PubMed: 30551450
Neferine inhibits growth and migration of gastrointestinal stromal tumor cell line GIST-T1 by up-regulation of miR-449a [FangxiXue, et al. Biomedicine & Pharmacotherapy, 2018, 10.1016/j.biopha.2018.11.029]
Correction: Auranofin Inhibits Retinal Pigment Epithelium Cell Survival through Reactive Oxygen Species-Dependent Epidermal Growth Factor Receptor/ Mitogen-Activated Protein Kinase Signaling Pathway [ PLoS One, 2017, 12(2):e0172599] PubMed: 28222166
Oxidative stress affects retinal pigment epithelial cell survival through epidermal growth factor receptor/AKT signaling pathway [Chen XD, et al. Int J Ophthalmol, 2017, 10(4):507-514] PubMed: 28503420

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。